The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKainos Group Regulatory News (KNOS)

Share Price Information for Kainos Group (KNOS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 945.00
Bid: 937.00
Ask: 941.00
Change: 4.00 (0.43%)
Spread: 4.00 (0.427%)
Open: 934.00
High: 946.00
Low: 934.00
Prev. Close: 941.00
KNOS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

8 Jul 2019 13:24

RNS Number : 8238E
Kainos Group plc
08 July 2019
 

8 July 2019

 

Kainos Group plc

 

("Kainos" or the "Company")

Director / PDMR shareholdings

The Company announces that on 8 July 2019, share awards (the "Awards") approved by the Board of Directors of the Company under the Kainos Group Performance Share Plan (the "PSP Awards"), in the form of nominal value options over Ordinary Shares were awarded to executive directors and executive managers of the Company. The PSP Awards vest, other than in exceptional circumstances, over a three year period from 8 July 2019. The performance conditions associated with the PSP Awards are as follows:

(a) 30% of each PSP Award is subject to a performance condition based on the Company's Earnings Per Share ("EPS") Growth measured over the three financial years commencing 1 April 2019. This portion of the PSP Award will:

· not vest at all if EPS Growth over the measurement period is less than 5%;

· vest in respect of 30% if EPS Growth over the measurement period is 5%;

· vest in full if EPS Growth over the measurement period is 13% or higher;

· vest proportionately, calculated on a straight line basis if EPS Growth over the measurement period is higher than 5% but less than 13%.

 

(b) 50% of each PSP Award is subject to a performance condition based on the Company's Total Shareholder Return ("TSR") performance compared with the FTSE techMARK index measured over the period of three years commencing 8 July 2019. This portion of the PSP Award will:

· not vest at all if TSR performance over the measurement period is below the median TSR for the FTSE techMARK index;

· vest in respect of 30% if TSR performance over the measurement period is at the median TSR for the FTSE techMARK index;

· vest in full if TSR performance over the measurement period is at or above the upper quartile of the TSR for the FTSE techMARK index;

· vest proportionately, calculated on a straight line basis if TSR performance over the measurement period is greater than the median but less than the upper quartile compared with the FTSE techMARK index.

 

(c) 20% of each PSP Award is subject to a performance condition based on the Company's performance in the Best Companies Survey. This portion of the PSP Award will:

· vest in full if the Company achieves a Best Companies Survey Best Companies Index ("BCI") score at least equal to the Company's BCI score at the beginning of the measurement period;

· not vest at all if the Company achieves a Best Companies Survey BCI score lower than at the beginning of the measurement period.

 

 

 

 

 

 

Notification and public disclosure of transactions by persons discharging

managerial responsibilities and persons closely associated with them.

 (A19 Market Abuse Regulation)

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a.

Name

Brendan Mooney

2.

Reason for the notification

a.

Position/status

CEO

b.

Initial notification

/Amendment

Initial

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Kainos Group plc

b.

LEI

213800H2PQMIF3OVZY47

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the

Financial instrument/

type of instrument

Identification code

Options over Ordinary Shares of £0.005 each

 

KNOS

b.

Nature of the transaction

PSP Share Awards 2019

c.

Price(s) and volume(s)

 

PSP Award1

Exercise Price(s)

Volume(s)

£0.005

13,140

 

1. Subject to the PSP Awards vesting criteria.

 

 

d.

Aggregated information

· Aggregated volume

· Price

 

N/A

e.

Date of the transaction

08-07-19

f.

Place of the transaction

Outside a trading venue

 

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a.

Name

Richard McCann

2.

Reason for the notification

a.

Position/status

CFO/COO

b.

Initial notification

/Amendment

Initial

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Kainos Group plc

b.

LEI

213800H2PQMIF3OVZY47

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the

Financial instrument/

type of instrument

Identification code

Options over Ordinary Shares of £0.005 each

 

KNOS

b.

Nature of the transaction

PSP Share Awards 2019

c.

Price(s) and volume(s)

 

PSP Award1

Exercise Price(s)

Volume(s)

£0.005

14,580

 

1. Subject to the PSP Awards vesting criteria.

 

d.

Aggregated information

· Aggregated volume

· Price

 

N/A

e.

Date of the transaction

08-07-19

f.

Place of the transaction

Outside a trading venue

 

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a.

Name

Paul Gannon

2.

Reason for the notification

a.

Position/status

Sales Director

b.

Initial notification

/Amendment

Initial

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Kainos Group plc

b.

LEI

213800H2PQMIF3OVZY47

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the

Financial instrument/

type of instrument

Identification code

Options over Ordinary Shares of £0.005 each

 

KNOS

b.

Nature of the transaction

PSP Share Awards 2019

c.

Price(s) and volume(s)

 

PSP Award1

Exercise Price(s)

Volume(s)

£0.005

11,700

 

1. Subject to the PSP Awards vesting criteria.

d.

Aggregated information

· Aggregated volume

· Price

 

N/A

e.

Date of the transaction

08-07-19

f.

Place of the transaction

Outside a Trading Venue

 

Kainos Group plc Legal Entity Identifier: 213800H2PQMIF3OVZY47 

 

 

 

Ends

 

For further information, please contact:

 

Kainos via FTI Consulting LLP

Brendan Mooney, Chief Executive Officer

Richard McCann, Chief Financial Officer

 

Investec Bank plc +44 20 7597 5970

Patrick Robb / Sebastian Lawrence

 

Canaccord Genuity +44 20 7523 4606

Simon Bridges / Emma Gabriel

 

FTI Consulting LLP +44 20 3727 1000

Matt Dixon / Harry Staight

 

About Kainos

Kainos Group plc is a UK-headquartered provider of Digital Services and Digital Platforms. 

 

The Group's Digital Services include full lifecycle development and support of customised Digital Services for government and commercial customers. Kainos is also the leading European partner for Workday, Inc. ('Workday'), responsible for implementing Workday's innovative Software-as-a-Service (SaaS) platform for enterprise and, now, government customers. 

 

The Group's Digital Platforms comprise specialised digital platforms in the mobile healthcare and automated testing arenas. Smart is an automated testing platform for Workday customers; Evolve Electronic Medical Records ('EMR') is the market-leading product for the digitisation of patient notes in the Acute sector of the NHS.

 

Kainos has over 1,470 people across 12 offices in Europe and North America. 

 

Kainos is listed on the London Stock Exchange (LSE: KNOS). For further information, please visit www.kainos.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHCKFDBBBKDKOK
Date   Source Headline
15th Apr 20247:00 amRNSYear-end Trading Update
11th Apr 20243:50 pmRNSHolding(s) in Company
2nd Apr 202412:12 pmRNSTotal Voting Rights
15th Mar 20241:48 pmRNSHolding(s) in Company
28th Feb 20243:16 pmRNSHolding(s) in Company
5th Feb 202412:51 pmRNSHolding(s) in Company
1st Feb 20244:29 pmRNSHolding(s) in Company
1st Feb 20244:21 pmRNSHolding(s) in Company
1st Feb 202412:13 pmRNSTotal Voting Rights
31st Jan 20244:09 pmRNSDirector/PDMR Shareholding
2nd Jan 202412:15 pmRNSTotal Voting Rights
22nd Dec 20239:21 amRNSExecutive Director PSP Award/PDMR shareholdings
1st Dec 20239:35 amRNSTotal Voting Rights
17th Nov 202311:13 amRNSExecutive Director PSP Award/PDMR shareholdings
13th Nov 20237:00 amRNSInterim Results
1st Nov 202310:48 amRNSTotal Voting Rights
2nd Oct 202312:41 pmRNSTotal Voting Rights
2nd Oct 20237:00 amRNSConfirmation of Board Changes
27th Sep 20235:52 pmRNSDirector/PDMR Shareholding
21st Sep 20232:54 pmRNSResults of Annual General Meeting
21st Sep 202311:59 amRNSConfirmation of CEO appointment
1st Sep 202312:34 pmRNSTotal Voting Rights
31st Aug 20237:00 amRNSTrading Update
10th Aug 20232:48 pmRNSNotice of AGM
3rd Aug 202310:41 amRNSMount Charles & Bankmore Square, Belfast
1st Aug 20234:02 pmRNSHolding(s) in Company
1st Aug 20233:58 pmRNSTotal Voting Rights
21st Jul 20235:11 pmRNSAnnual Report 2023
3rd Jul 20231:20 pmRNSTotal Voting Rights
3rd Jul 20237:00 amRNSAcquisition of RapidIT-Cloudbera, Inc.
23rd Jun 202312:55 pmRNSDirector/PDMR Shareholding
19th Jun 20237:00 amRNSPlanned CEO Transition
1st Jun 202311:23 amRNSTotal Voting Rights
23rd May 20234:36 pmRNSHolding(s) in Company
22nd May 20237:00 amRNSFinal Results
3rd May 20235:21 pmRNSHolding(s) in Company
2nd May 20237:00 amRNSAppointment of Independent Non-Executive Director
19th Apr 20237:00 amRNSTrading Statement
3rd Apr 20232:30 pmRNSTotal Voting Rights
17th Mar 20235:05 pmRNSHolding(s) in Company
1st Mar 202312:07 pmRNSTotal Voting Rights
1st Feb 20239:35 amRNSTotal Voting Rights
30th Dec 20229:53 amRNSTotal Voting Rights
29th Dec 202210:20 amRNSHolding(s) in Company
21st Dec 20224:58 pmRNSHolding(s) in Company
20th Dec 20224:15 pmRNSDirector/PDMR Shareholding
7th Dec 20228:40 amRNSHolding(s) in Company
1st Dec 202212:10 pmRNSTotal Voting Rights
18th Nov 20224:38 pmRNSDirector/PDMR Shareholding
14th Nov 20227:00 amRNSHalf-year Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.